What is the impact of PRIME on real-life diabetic nephropathy?RUILOPE, L. M.International journal of clinical practice (Esher). 2004, Vol 58, Num 3, pp 268-276, issn 1368-5031, 9 p.Article

Can we prevent or delay diabetic nephropathy ?BILOUS, R. W.Journal of the Royal College of Physicians of London. 1997, Vol 31, Num 1, pp 22-27, issn 0035-8819Article

2 Grossesse et néphropathie diabétique: Comment limiter les complications? : DIABETE, OBESITE ET GROSSESSE (1re partie): Les clés pour améliorer le pronostic maternel et foetalLORENZINI, Françoise.Diabète & obésité. 2013, Vol 8, Num 69, pp 162-164, issn 1957-5238, 3 p.Article

Proteomics in diabetic nephropathyKIM, Hyun-Jung; YOO, Hyun-Syuk; KIM, Chan-Wha et al.Proteomics. Clinical applications (Print). 2008, Vol 2, Num 3, pp 301-311, issn 1862-8346, 11 p.Article

Recent advances in diabetic nephropathyMARSHALL, S. M.Postgraduate medical journal. 2004, Vol 80, Num 949, pp 624-633, issn 0032-5473, 10 p.Article

Urinary albumin excretion in latent autoimmune diabetes in adults (LADA) is more similar to type 2 than type 1 diabetes: Results of the Nord- Trøndelag Health Study 1995-1997RADTKE, M. A; NILSEN, T. I. Lund; MIDTHJELL, K et al.Diabetes & metabolism. 2009, Vol 35, Num 4, pp 273-279, issn 1262-3636, 7 p.Article

Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathyCOCCHIETTO, M; ZORZIN, L; TOFFOLI, B et al.Diabetes & metabolism. 2008, Vol 34, Num 6, pp 587-594, issn 1262-3636, 8 p., 1Article

Le patient diabétique : un insuffisant rénal comme les autres ?ROSSERT, Jérome.Néphrologie & thérapeutique. 2006, Vol 2, issn 1769-7255, S187-S189, SUP3Article

Néphropathie diabétique : Devons-nous revenir à la mesure du débit de filtration glomérulaire ?HADJADJ, S; SOSNER, P; BRIDOUX, F et al.Diabétologie, nutrition et facteurs de risque. 2005, Vol 11, Num 90, pp 41-47, 7 p.Article

Les effets physiologiques du peptide connecteur = Physiological effects of C-peptideTSIMARATOS, M.Néphrologie (Genève). 2004, Vol 25, Num 5, pp 155-161, issn 0250-4960, 7 p.Article

Études cliniques chez les diabétiques insuffisants rénaux chroniques et données récentes concernant la prévention des risques de néphropathie et de maladie cardiovasculaireESNAULT, Vincent.Néphrologie & thérapeutique. 2006, Vol 2, issn 1769-7255, S193-S196, SUP3Article

Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetesRIGALLEAU, V; BEAUVIEUX, M.-C; LE MOIGNE, F et al.Diabetes & metabolism. 2008, Vol 34, Num 5, pp 482-489, issn 1262-3636, 8 p.Article

La ponction biopsie renale chez le diabetique : Interet et resultats = Renal biopsy findings in diabetes mellitusKHARRAT, Mahmoud; KAMMOUN, Khawala; CHARFEDDINE, Khaled et al.Tunisie médicale. 2007, Vol 85, Num 3, pp 216-219, issn 0041-4131, 4 p.Article

Néphropathie diabétique: traitements émergents = Diabetic nephropathy: Emerging treatmentsGUEUTIN, Victor; GAUTHIER, Marion; CAZENAVE, Maud et al.Néphrologie & thérapeutique. 2014, Vol 10, Num 4, pp 210-215, issn 1769-7255, 6 p.Article

Les effets physiologiques du peptide connecteur = Physiological effects of the connecting peptideTSIMARATOS, M.Archives de pédiatrie (Paris). 2005, Vol 12, Num 4, pp 442-448, issn 0929-693X, 7 p.Article

Rein et glitazones = Kidney and glitazonesDERAY, G; IZZEDINE, H; LAUNAY-VACHER, V et al.Annales d'endocrinologie. 2005, Vol 66, Num 2, pp 1S81-1S90, issn 0003-4266, CAH2Conference Paper

Association Testing of Previously Reported Variants in a Large Case-Control Meta-analysis of Diabetic NephropathyWILLIAMS, WinfredW; SALEM, RanyM; BRENNAN, Eoin P et al.Diabetes (New York, NY). 2012, Vol 61, Num 8, pp 2187-2194, issn 0012-1797, 8 p.Article

Néphropathie diabétique : NEPHROLOGIE = Diabetic nephropathy an updateGARIANI, K; DE SEIGNEUX, S; PECHERE-BERTSCHI, A et al.Revue médicale suisse. 2012, Vol 8, Num 330, pp 473-479, issn 1660-9379, 7 p.Article

ROLE OF GROWTH ARREST-SPECIFIC GENE 6 IN DIABETIC NEPHROPATHYARAI, Hidenori; NAGAI, Kojiro; DOI, Toshio et al.Vitamins and hormones. 2008, Vol 78, pp 375-392, issn 0083-6729, 18 p.Article

From the periphery of the glomerular capillary wall toward the center of disease: Podocyte injury comes of age in diabetic nephropathyWOLF, Gunter; CHEN, Sheldon; ZIYADEH, Fuad N et al.Diabetes (New York, NY). 2005, Vol 54, Num 6, pp 1626-1634, issn 0012-1797, 9 p.Article

Slowing the progression of diabetic nephropathy and its cardiovascular consequencesMCCULLOUGH, Peter A; BAKRIS, George L; OWEN, William F et al.The American heart journal. 2004, Vol 148, Num 2, pp 243-251, issn 0002-8703, 9 p.Article

Diabetic nephropathyWYLIE, Emma C; SATCHELL, Simon C.Clinical medicine. 2012, Vol 12, Num 5, pp 480-482, issn 1470-2118, 3 p.Article

Managing diabetic nephropathySHIELDS, Joanne; MAXWELL, Alexander P.Clinical medicine. 2010, Vol 10, Num 5, pp 500-504, issn 1470-2118, 5 p.Article

Human Recombinant ACE2 Reduces the Progression of Diabetic NephropathyOUDIT, Gavin Y; LIU, George C; HERZENBERG, Andrew M et al.Diabetes (New York, NY). 2010, Vol 59, Num 2, pp 529-538, issn 0012-1797, 10 p.Article

Familial factors in diabetic nephropathy : an offspring studyAGIUS, E; ATTARD, G; SHAKESPEARE, L et al.Diabetic medicine. 2006, Vol 23, Num 3, pp 331-334, issn 0742-3071, 4 p.Article